Rather, the FDA recommended the generation of a brand name-new regulatory pathway that may incorporate safeguards for instance a bare minimum authorized purchase age. But building such a pathway would call for an act of Congress — anything not likely to occur shortly.Nevertheless, depending on available evidence, FDA has concluded that none of th… Read More